Due to a non-cash impairment charge of up to USD 960 million related to its acquired sports drink brand BodyArmor, Coca-Cola's Q4 GAAP operating profit declined by 32% year-over-year. Coca-Cola forecasts full-year organic sales growth for 2026 to be between 4% and 5%, with the lower end of this guidance range falling below Wall Street's average expectation of 5.01%. After years of driving growth through price increases, investors are concerned that this consumer giant’s growth engine is decelerating as consumers become more price-sensitive.
Despite the continued strong performance of the zero-sugar series and slightly better-than-expected Q4 results, the growth guidance for 2026 appears somewhat lackluster against the backdrop of cooling inflation and diminishing pricing power dividends, which has disappointed the market. $Coca-Cola (KO.US)$ Moreover, Coca-Cola is facing an increasingly complex macro-policy environment. On one hand, the Trump administration has sent sharp signals regarding the unhealthy nature of carbonated beverages; on the other hand, some U.S. states are implementing new plans to restrict food aid beneficiaries from purchasing soft drinks. Affected by weaker-than-expected guidance and macroeconomic concerns, Coca-Cola shares fell more than 4% in pre-market trading on Wall Street.
On February 10, global beverage giant Coca-Cola released its Q4 and full-year financial results for 2025. The report showed that the company’s Q4 revenue reached $11.82 billion, up 2% year-over-year, with organic revenue growth of 5%. Comparable earnings per share (EPS) stood at $0.58, growing 6% year-over-year, slightly exceeding analysts' average expectations.
However, due to a $960 million non-cash impairment charge related to its acquired sports drink brand BodyArmor, Coca-Cola's Q4 GAAP operating profit fell by 32% year-over-year.
The market's strongest reaction was to the company's future outlook. Coca-Cola projected its organic sales growth for 2026 to be between 4% and 5%, with the lower end of the range falling below Wall Street's average expectation of 5.01%. After years of growth driven by price increases, rising consumer price sensitivity has led investors to worry that this consumer giant's growth engine is slowing down.
In addition, Coca-Cola is facing an increasingly complex macro-policy environment. On one hand, the Trump administration has been sending sharp signals regarding the unhealthiness of carbonated beverages; on the other hand, some U.S. states are implementing new plans to restrict food aid beneficiaries from purchasing soft drinks. Impacted by weaker-than-expected guidance and macroeconomic concerns, Coca-Cola's stock fell more than 4% in pre-market trading on Wall Street.
2026 Guidance Falls Short of Expectations, Growth Returns to Normalization
The most concerning aspect of this earnings report for investors is the 2026 guidance. Coca-Cola expects its organic revenue growth for 2026 to be between 4% and 5%, below the average analyst forecast of over 5%. For earnings per share, the company anticipates a 7% to 8% increase from the 2025 base of $3.00 (including approximately 3% tailwind from currency effects), suggesting that the company is transitioning from the 'price hike boom' driven by high inflation in recent years to a more moderate growth norm.
The challenge for incoming CEO Henrique Braun is that as consumers shift from traditional high-calorie soft drinks to healthier options, the company must accelerate its expansion into categories such as sugar-free beverages, sports drinks, and water. Although the company remains optimistic, the weak guidance indicates that management is adopting a cautious stance toward the consumption environment in the coming year.
Q4 Performance: Zero-Sugar Coke Remains the Biggest Highlight
Returning to the specific performance of Q4 2025, Coca-Cola demonstrated resilience in its core business, particularly with significant success from its 'zero-sugar' strategy:
Sales Volume and Pricing: Global unit case volume increased by 1%, with price/mix growth also at 1%. This indicates that the company maintained a certain level of pricing power despite only marginal sales growth, although the extent of price increases has significantly narrowed compared to previous years.
Category Performance: Coca-Cola Zero Sugar once again emerged as a standout product, with sales surging 13% in Q4 and up 14% for the full year. In contrast, traditional full-sugar sodas faced pressure due to weakening consumer demand. Diet Coke saw a 2% increase in Q4, remaining flat for the year.
Other Categories: Sales of water, sports drinks, coffee, and tea grew by 3% in Q4, showing solid performance. However, juice, dairy, and plant-based beverages declined by 3%, primarily impacted by downturns in the Asia-Pacific and EMEA (Europe, Middle East, and Africa) regions.
BodyArmor Fallout Impacts North American Profitability
Despite relatively strong revenue performance, the profit side of the North American market encountered a 'black swan' event. Financial reports showed a 65% year-over-year plunge in operating profit in Q4 for the North American region, primarily due to a $960 million non-cash impairment charge related to the BodyArmor trademark.
BodyArmor was a high-profile acquisition by Coca-Cola aimed at catching up with PepsiCo's Gatorade in the sports drink sector. However, this substantial impairment indicates that the brand’s performance after integration into Coca-Cola’s system fell short of management’s initial expectations. Intense market competition forced the company to reassess the asset’s value.
Excluding one-time factors such as impairments, the fundamentals of the North American market remained robust, with unit case volume growing by 1% in Q4, price/mix increasing by 4%, and comparable currency-neutral operating profit rising by 15%.
Macroeconomic Headwinds: Balancing Policy Pressures and Health Trends
Beyond financial data, Coca-Cola subtly referenced external environmental challenges in its earnings report. With growing consumer health awareness, sugary beverages are facing headwinds.
More severe is the pressure from policy measures. Currently, state-level programs in the United States have begun restricting the use of food assistance benefits to purchase soft drinks, directly impacting the purchasing power of low-income groups. Additionally, recent tough statements from the Trump administration on soda health concerns could pose potential threats to brand image and long-term demand.
To address these challenges, Coca-Cola is accelerating the diversification of its product portfolio. The earnings report shows that the company is vigorously promoting innovative products such as Powerade Power Water and leveraging global sporting events (such as the South American World Cup qualifiers) for marketing. By emphasizing sports and health attributes, Coca-Cola aims to hedge against the declining risks associated with traditional carbonated beverages.
Editor/Jayden
